+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoimmune Disease Diagnosis Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446192
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Abbott
  • BioMerieux SA
  • Exagen Inc.
  • Haemonetics Corporation
  • INOVA Diagnostics
  • Quest Diagnostics
Autoimmune Disease Diagnosis Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global autoimmune disease diagnosis market.







This report focuses on the autoimmune disease diagnosis market which is experiencing strong growth. The report gives a guide to the autoimmune disease diagnosis market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for autoimmune disease diagnosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Autoimmune Disease Diagnosis market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider autoimmune disease diagnosis market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The autoimmune disease diagnosis market section of the report gives context. It compares the autoimmune disease diagnosis market with other segments of the autoimmune disease diagnosis market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, autoimmune disease diagnosis indicators comparison.

Scope


Markets Covered:


  • By Product: Consumables & Assay Kits; Instruments
  • By Test Type: Routine Laboratory Tests; Autoantibodies Tests; Immunologic Tests; Other Tests
3) By End User: Clinical Laboratories; Hospitals; Other End Users

Companies Mentioned:


Thermo Fisher Scientific; Siemens Healthineers; Abbott; Danaher; Bio-Rad Laboratories

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Autoimmune Disease Diagnosis Market

What is the estimated value of the Global Autoimmune Disease Diagnosis Market?

The Global Autoimmune Disease Diagnosis Market was estimated to be valued at $4.2 billion in 2021.

What is the growth rate of the Global Autoimmune Disease Diagnosis Market?

The growth rate of the Global Autoimmune Disease Diagnosis Market is 8.5%, with an estimated value of $5.8 billion by 2025.

What is the forecasted size of the Global Autoimmune Disease Diagnosis Market?

The Global Autoimmune Disease Diagnosis Market is estimated to be worth $5.8 billion by 2025.

Who are the key companies in the Global Autoimmune Disease Diagnosis Market?

Key companies in the Global Autoimmune Disease Diagnosis Market include Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio, Rad Laboratories, Trinity Biotech, HYCOR Biomedical and AESKU GROUP GMBH & CO. KG.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • BioMerieux SA
  • Exagen Inc.
  • Haemonetics Corporation
  • INOVA Diagnostics
  • Quest Diagnostics

1. Executive Summary2. Autoimmune Disease Diagnosis Market Characteristics3. Autoimmune Disease Diagnosis Market Trends and Strategies4. Impact Of COVID-19 On Autoimmune Disease Diagnosis
5. Autoimmune Disease Diagnosis Market Size and Growth
5.1. Global Autoimmune Disease Diagnosis Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Autoimmune Disease Diagnosis Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Autoimmune Disease Diagnosis Market Segmentation
6.1. Global Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Consumables & Assay Kits
  • Instruments
6.2. Global Autoimmune Disease Diagnosis Market, Segmentation by Test Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Routine Laboratory Tests
  • Autoantibodies Tests
  • Immunologic Tests
  • Other Tests
6.3. Global Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Clinical Laboratories
  • Hospitals
  • Other End Users

7. Autoimmune Disease Diagnosis Market Regional and Country Analysis
7.1. Global Autoimmune Disease Diagnosis Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Autoimmune Disease Diagnosis Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Autoimmune Disease Diagnosis Market
8.1. Asia-Pacific Autoimmune Disease Diagnosis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Autoimmune Disease Diagnosis Market
9.1. China Autoimmune Disease Diagnosis Market Overview
9.2. China Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Autoimmune Disease Diagnosis Market
10.1. India Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Autoimmune Disease Diagnosis Market
11.1. Japan Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Autoimmune Disease Diagnosis Market
12.1. Australia Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Autoimmune Disease Diagnosis Market
13.1. Indonesia Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Autoimmune Disease Diagnosis Market
14.1. South Korea Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Autoimmune Disease Diagnosis Market
15.1. Western Europe Autoimmune Disease Diagnosis Market Overview
15.2. Western Europe Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Autoimmune Disease Diagnosis Market
16.1. UK Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Autoimmune Disease Diagnosis Market
17.1. Germany Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Autoimmune Disease Diagnosis Market
18.4. France Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Autoimmune Disease Diagnosis Market
19.1. Eastern Europe Autoimmune Disease Diagnosis Market Overview
19.2. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Autoimmune Disease Diagnosis Market
20.1. Russia Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Autoimmune Disease Diagnosis Market
21.1. North America Autoimmune Disease Diagnosis Market Overview
21.2. North America Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Autoimmune Disease Diagnosis Market
22.1. USA Autoimmune Disease Diagnosis Market Overview
22.2. USA Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Autoimmune Disease Diagnosis Market
23.1. South America Autoimmune Disease Diagnosis Market Overview
23.2. South America Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Autoimmune Disease Diagnosis Market
24.1. Brazil Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Autoimmune Disease Diagnosis Market
25.1. Middle East Autoimmune Disease Diagnosis Market Overview
25.2. Middle East Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Autoimmune Disease Diagnosis Market
26.1. Africa Autoimmune Disease Diagnosis Market Overview
26.2. Africa Autoimmune Disease Diagnosis Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Autoimmune Disease Diagnosis Market Competitive Landscape and Company Profiles
27.1. Autoimmune Disease Diagnosis Market Competitive Landscape
27.2. Autoimmune Disease Diagnosis Market Company Profiles
27.2.1. Thermo Fisher Scientific
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Siemens Healthineers
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Abbott
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Danaher
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Bio-Rad Laboratories
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Autoimmune Disease Diagnosis Market29. Autoimmune Disease Diagnosis Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • BioMerieux SA
  • Exagen Inc.
  • Haemonetics Corporation
  • INOVA Diagnostics
  • Quest Diagnostics
Major players in the autoimmune disease diagnosis market are Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio-Rad Laboratories, Trinity Biotech, Hycor Biomedical, Euroimmun AG, and Aesku Group GMBH & CO. KG.

The global autoimmune disease diagnosis market is expected to grow from $3.38 billion in 2020 to $4.15 billion in 2021 at a compound annual growth rate (CAGR) of 22.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $5.75 billion in 2025 at a CAGR of 8%.

The market for autoimmune disease diagnosis consists of sales of diagnostic assay kits, reagents, consumables and instruments used for the diagnosis of autoimmune diseases. Autoimmune diseases are the diseases in which the production of antibodies takes place in the body which attacks and destroys own healthy cells in the body. These include Crohn's disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus and inflammatory bowel syndrome, and are diagnosed by immunological tests.

The autoimmune disease diagnosis market covered in this report is segmented by product into consumables & assay kits, instruments. It is also segmented by test type into routine laboratory tests, autoantibodies tests, immunologic tests, other tests and by end-user into clinical laboratories, hospitals, other end-users.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The high cost of diagnostic tests is a major challenge for the growth of the autoimmune disease diagnosis market. According to a survey by the National Adrenal Diseases Foundation (NADF), the cost for initial diagnosis of Addison’s disease is $1,680 per patient and according to the reports of Vasculitis Foundation of America, vasculitis affects 1 in 20 Americans and the total cost for vasculitis patient per year is $9.7 billion. According to the estimations of The National Institutes of Allergy and Infectious Diseases (NIAID), the annual cost of treating an autoimmune disease in the US is greater than $100 billion and says that annual direct and indirect cost to treat rheumatoid arthritis in the US is $10.9 billion and $8.4 billion respectively. The high cost of diagnosis is increasing the cost burdens on the patients impacting the growth of the autoimmune disease diagnosis market

A high incidence of autoimmune diseases contributed to the growth of the autoimmune disease diagnosis market. The percentage of the adult population diagnosed with autoimmune diseases in 2019 across countries was 7% in the US, 6% in Europe, 5% in China, 3% each in Brazil and Russia and Japan 2%. According to a report by Connect Immune Research published in 2018, the incidence of autoimmune diseases in the UK is increasing, which ranges between 3% and 9% year-on-year. In these, different autoimmune conditions such as rheumatoid arthritis 7%, type 1 diabetes 6.3%, multiple sclerosis 3.7%, coeliac disease 4-9% cases are increasing every year and the number of people in the UK with at least one autoimmune condition is 4 million. Therefore, increasing incidence of autoimmune diseases across the globe is driving the autoimmune disease diagnosis market.

Biosensors and nano biosensors for rapid detection is a novel tool for the detection of antibodies in the autoimmune disease diagnosis market. They are highly preferred because of low cost, high sensitivity, simple to use, multiplexing abilities and rapid diagnosis. Besides measuring the quantity of antibodies in human blood serum with extremely high sensitivity, it also quantifies the activity of antibodies as the assay employs portable optical label-free biosensors based on the spectral correlation interferometry. This point of care technology gives a more integrated, informative, timely and precise diagnosis of autoimmune diseases when compared to the conventional ones.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Abbott
  • Danaher
  • Bio-Rad Laboratories
  • Trinity Biotech
  • HYCOR Biomedical
  • EUROIMMUN AG
  • AESKU GROUP GMBH & CO. KG
  • F. Hoffmann-La Roche Ltd
  • Beckman Coulter
  • SQI Diagnostics
  • Quest Diagnostics
  • INOVA Diagnostics
  • BioMerieux SA
  • Hemagen Diagnostics
  • Grifols
  • Sanofi-Aventis
  • Haemonetics Corporation
  • Fresenius Kabi
  • Asahi Kasei Kuraray Medical Co. Ltd
  • Terumo BCT
  • AstraZeneca
  • Oncimmune
  • HTG Molecular Diagnostics
  • Seramun Diagnostica GmbH
  • Exagen Inc.
  • Cambridge Life Sciences Limited
  • A. Menarini Diagnostics s.r.l
  • ORGENTEC Diagnostika
  • KRONUS
Note: Product cover images may vary from those shown

Loading
LOADING...